Yu Ding

17PUBLICATIONS
37CO-AUTHORS
Clinical pharmacology and therapeuticsMolecular targetsCharacterisation of biological macromoleculesNeurology and neuromuscular diseasesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 16, 2026
Molecular basis of antagonism of the dimeric human arginine vasopressin receptor 1A.

Peiyu Zhong, Bingxin Chu, Zijing Yu

|Dec 05, 2025
Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopes.

Shihao Cheng, Chao Zhong, Haoran Zhu

|May 28, 2025
Nanobodies: From Discovery to AI-Driven Design.

|May 14, 2025
MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson's disease.

Huilan Wang, Qing Wang, Haoxiang Xu

|Mar 27, 2025
R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation.

Chao Zhong, Xiaoge Gao, Qi Chen

|Apr 01, 2024
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia.

Kexin Jiao, Nachuan Cheng, Xiao Huan

Pageof 3

Frequent Collaborators

6 joint publications

Boxun Lu

5 joint publications

Yiyan Fei

2 joint publications

Chao Zhong

2 joint publications

Rui Liu